223 related articles for article (PubMed ID: 37508543)
1. Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells.
Zeng K; Huang M; Lyu MA; Khoury JD; Ahmed S; Patel KK; Dropulić B; Reese-Koc J; Caimi PF; Sadeghi T; Lima M; Flowers CR; Parmar S
Cells; 2023 Jul; 12(14):. PubMed ID: 37508543
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
[TBL] [Abstract][Full Text] [Related]
3. Allogeneic cord blood regulatory T cells can resolve lung inflammation.
Lyu MA; Huang M; Zeng K; Li L; Khoury JD; Nishimoto M; Ma H; Sadeghi T; Mukherjee S; Slutsky AS; Flowers CR; Parmar S
Cytotherapy; 2023 Mar; 25(3):245-253. PubMed ID: 36437190
[TBL] [Abstract][Full Text] [Related]
4. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
[TBL] [Abstract][Full Text] [Related]
5. CD4
Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
[TBL] [Abstract][Full Text] [Related]
6. Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells.
Caël B; Galaine J; Bardey I; Marton C; Fredon M; Biichle S; Poussard M; Godet Y; Angelot-Delettre F; Barisien C; Bésiers C; Adotevi O; Pouthier F; Garnache-Ottou F; Bôle-Richard E
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804941
[TBL] [Abstract][Full Text] [Related]
7. Suppressive Characteristics of Umbilical Cord Blood-derived Regulatory T Cells After Ex Vivo Expansion on Autologous and Allogeneic T Effectors and Various Lymphoblastic Cells.
Vanichapol T; Pongsakul N; Srisala S; Apiwattanakul N; Chutipongtanate S; Hongeng S
J Immunother; 2019 May; 42(4):110-118. PubMed ID: 30921263
[TBL] [Abstract][Full Text] [Related]
8. Trafficking and persistence of alloantigen-specific chimeric antigen receptor regulatory T cells in Cynomolgus macaque.
Ellis GI; Coker KE; Winn DW; Deng MZ; Shukla D; Bhoj V; Milone MC; Wang W; Liu C; Naji A; Duran-Struuck R; Riley JL
Cell Rep Med; 2022 May; 3(5):100614. PubMed ID: 35551746
[TBL] [Abstract][Full Text] [Related]
9. The altering cellular components and function in tumor microenvironment during remissive and relapsed stages of anti-CD19 CAR T-cell treated lymphoma mice.
Zhao K; Ren C; Tang D; Zhao L; Chen X; Wang Y; Xu K
Front Immunol; 2023; 14():1101769. PubMed ID: 36761733
[TBL] [Abstract][Full Text] [Related]
10. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
[TBL] [Abstract][Full Text] [Related]
11. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
[TBL] [Abstract][Full Text] [Related]
12. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
Front Immunol; 2021; 12():686439. PubMed ID: 34616392
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Antigen Receptor (CAR) Treg: A Promising Approach to Inducing Immunological Tolerance.
Zhang Q; Lu W; Liang CL; Chen Y; Liu H; Qiu F; Dai Z
Front Immunol; 2018; 9():2359. PubMed ID: 30369931
[TBL] [Abstract][Full Text] [Related]
14. Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application.
Henschel P; Landwehr-Kenzel S; Engels N; Schienke A; Kremer J; Riet T; Redel N; Iordanidis K; Saetzler V; John K; Heider M; Hardtke-Wolenski M; Wedemeyer H; Jaeckel E; Noyan F
J Autoimmun; 2023 Jul; 138():103057. PubMed ID: 37224732
[TBL] [Abstract][Full Text] [Related]
15. Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion.
Lamarche C; Ward-Hartstonge K; Mi T; Lin DTS; Huang Q; Brown A; Edwards K; Novakovsky GE; Qi CN; Kobor MS; Zebley CC; Weber EW; Mackall CL; Levings MK
Proc Natl Acad Sci U S A; 2023 Apr; 120(14):e2219086120. PubMed ID: 36972454
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients.
Sicard A; Lamarche C; Speck M; Wong M; Rosado-Sánchez I; Blois M; Glaichenhaus N; Mojibian M; Levings MK
Am J Transplant; 2020 Jun; 20(6):1562-1573. PubMed ID: 31957209
[TBL] [Abstract][Full Text] [Related]
17. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia.
Pegram HJ; Purdon TJ; van Leeuwen DG; Curran KJ; Giralt SA; Barker JN; Brentjens RJ
Leukemia; 2015 Feb; 29(2):415-22. PubMed ID: 25005243
[TBL] [Abstract][Full Text] [Related]
18. In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy.
Lee JC; Hayman E; Pegram HJ; Santos E; Heller G; Sadelain M; Brentjens R
Cancer Res; 2011 Apr; 71(8):2871-81. PubMed ID: 21487038
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the inherent power of chimeric antigen receptor (CAR)-expressing regulatory T cells (CAR-Tregs) to treat autoimmune-related disorders.
Kahmini FR; Shahgaldi S
Mol Biol Rep; 2022 May; 49(5):4069-4078. PubMed ID: 35534581
[TBL] [Abstract][Full Text] [Related]
20. Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival.
Wagner JC; Ronin E; Ho P; Peng Y; Tang Q
Am J Transplant; 2022 Sep; 22(9):2237-2245. PubMed ID: 35434896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
